£340K
The seed round was backed by returning angel investors and the Women Angels of the North Syndicate.
RareCan connects rare cancer patients with researchers to accelerate treatments and diagnostics.
RareCan is a Newcastle-based health research platform that connects rare cancer patients with researchers to accelerate treatments and diagnostics.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from RareCan's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Claire Heron
Co-founder
The seed round was backed by returning angel investors and the Women Angels of the North Syndicate.